Press Releases
Imago BioSciences Appoints Bob Baltera to Board of Directors
Apr 22, 2020
Imago BioSciences Appoints Edgardo Baracchini as Chief Business Officer
Apr 16, 2020
Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for Treatment of Essential Thrombocythemia
Jan 13, 2020
Imago BioSciences Preliminary Data from Ongoing Phase 2 Study of IMG-7289 for the Treatment of Myelofibrosis to be Presented at the 61st American Society of Hematology Annual Meeting & Exposition
Oct 25, 2019
Imago BioSciences Announces First Patient Dosed at European Site in Phase 2b Clinical Trial of IMG-7289 for Treatment of Myelofibrosis
Sep 19, 2019
Displaying 31 - 35 of 46